Literature DB >> 31482344

Open and Endovascular Management of Acute Mesenteric Ischaemia: A Systematic Review.

B Murphy1, C H C Dejong2, D C Winter3.   

Abstract

BACKGROUND: Acute mesenteric ischaemia (AMI) is a life-threatening surgical emergency resulting from thromboembolic occlusion of the mesenteric vasculature. Traditional management of AMI has been open revascularisation with or without bowel resection-a procedure which carries considerable morbidity and mortality in an already unwell, compromised patient. Endovascular and more minimally invasive management approaches to AMI have been reported. Proponents of endovascular management suggest this approach may be associated with reduced morbidity and mortality compared with open surgery.
OBJECTIVES: To assess the impact of endovascular approach for AMI on mortality and need for subsequent laparotomy and/or bowel resection. DATA SOURCES: The search bodies PubMed and Medline were interrogated. ELIGIBILITY CRITERIA, PARTICIPANTS AND
INTERVENTIONS: All studies in English with greater than 10 patients examining outcomes for patients undergoing endovascular intervention for acute mesenteric ischaemia were included. All patients over 18 years presenting with a diagnosis of acute mesenteric ischaemia secondary to an arterial thromboembolic source were included. Studies examining endovascular intervention alone or endovascular and open intervention were selected.
RESULTS: The 30-day mortality for endovascular approach from all 13 studies was 16-42%. Of the 7 comparative studies including results of open revascularisation, the 30-day mortality for patient treated with an endovascular approach was 15-39% versus 33-50% for open revascularisation. Laparotomy rates post-initial endovascular intervention ranged from 13 to 73%. Bowel resection post-endovascular therapy ranged from 14 to 40% among studies. Concerning 7 comparative studies for open versus endovascular revascularisation, the rate of bowel resection in the endovascular group ranged 14-28% and 33-63% in the open cohort. Endovascular intervention also demonstrated lower median length (s) of bowel resected. LIMITATIONS: Heterogeneity of studies and patient populations studied including selection bias. CONCLUSIONS AND IMPLICATIONS OF
FINDINGS: Endovascular management may be associated with reduced mortality and need for/length of bowel resection compared with the traditional open approach, but there remains a paucity of robust data to support this. The available literature illustrates that a subgroup of patients without haemodynamic compromise and more insidious onset may garner benefit from endovascular intervention.

Entities:  

Mesh:

Year:  2019        PMID: 31482344     DOI: 10.1007/s00268-019-05149-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  33 in total

1.  Outcome of endovascular revascularisation in patients with acute obstructive mesenteric ischaemia - a single-centre experience.

Authors:  Gilbert Dominique Puippe; Julian Suesstrunk; Antonio Nocito; Roger Pfiffner; Michael Glenck; Thomas Pfammatter
Journal:  Vasa       Date:  2015-09       Impact factor: 1.961

Review 2.  Acute mesenteric ischemia.

Authors:  James R Stone; Luke R Wilkins
Journal:  Tech Vasc Interv Radiol       Date:  2014-12-29

3.  Chronic mesenteric ischemia: open surgery versus percutaneous angioplasty and stenting.

Authors:  K Kasirajan; P J O'Hara; B H Gray; N R Hertzer; D G Clair; R K Greenberg; L P Krajewski; E G Beven; K Ouriel
Journal:  J Vasc Surg       Date:  2001-01       Impact factor: 4.268

4.  Long-Term Results of Endovascular Treatment of Atherosclerotic Stenoses or Occlusions of the Coeliac and Superior Mesenteric Artery in Patients With Mesenteric Ischaemia.

Authors:  T Bulut; R Oosterhof-Berktas; R H Geelkerken; M Brusse-Keizer; E J Stassen; J J Kolkman
Journal:  Eur J Vasc Endovasc Surg       Date:  2017-02-21       Impact factor: 7.069

Review 5.  Thrombophilia and venous thromboembolism: implications for testing.

Authors:  Danny M Cohn; Sara Roshani; Saskia Middeldorp
Journal:  Semin Thromb Hemost       Date:  2007-09       Impact factor: 4.180

6.  Mesenteric revascularization: management and outcomes in the United States, 1988-2006.

Authors:  Marc L Schermerhorn; Kristina A Giles; Allen D Hamdan; Mark C Wyers; Frank B Pomposelli
Journal:  J Vasc Surg       Date:  2009-04-16       Impact factor: 4.268

7.  Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: a comparative experience.

Authors:  Marvin D Atkins; Christopher J Kwolek; Glenn M LaMuraglia; David C Brewster; Thomas K Chung; Richard P Cambria
Journal:  J Vasc Surg       Date:  2007-04-30       Impact factor: 4.268

8.  Interventional treatment for symptomatic acute-subacute portal and superior mesenteric vein thrombosis.

Authors:  Feng-Yong Liu; Mao-Qiang Wang; Qing-Sheng Fan; Feng Duan; Zhi-Jun Wang; Peng Song
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

9.  Endovascular interventions decrease length of hospitalization and are cost-effective in acute mesenteric ischemia.

Authors:  Young Erben; Clinton D Protack; Raymond A Jean; Brandon J Sumpio; Samuel M Miller; Shirley Liu; Gerardo Trejo; Bauer E Sumpio
Journal:  J Vasc Surg       Date:  2018-02-16       Impact factor: 4.268

10.  Early endovascular treatment of superior mesenteric occlusion secondary to thromboemboli.

Authors:  Z Jia; G Jiang; F Tian; J Zhao; S Li; K Wang; Y Wang; L Jiang; W Wang
Journal:  Eur J Vasc Endovasc Surg       Date:  2013-10-02       Impact factor: 7.069

View more
  2 in total

1.  Endovascular management of acute mesenteric ischemia in a young patient with thyrotoxicosis and atrial fibrillation: A case report and review of the literature.

Authors:  Raed M Ennab; Mamoon H Al-Omari; Ihab I Jaradat; Alaa A A Aljabali
Journal:  Int J Surg Case Rep       Date:  2020-10-02

2.  Outcome Comparison of Endovascular and Open Surgery for the Treatment of Acute Superior Mesenteric Artery Embolism: A Retrospective Study.

Authors:  Wenrui Li; Saisai Cao; Zhiwen Zhang; Renming Zhu; Xueming Chen; Bin Liu; Hai Feng
Journal:  Front Surg       Date:  2022-03-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.